Tag: Preclinical

August 26, 2020

Seeking an answer, researchers at CHU Sainte-Justine Hospital and Université de Montréal have made a major discovery in understanding the mechanisms underlying learning and memory formation. The results of their study are presented today in Nature Communications. Led by Professor […]

May 20, 2020

Higher blood pressure during exercise and delayed blood pressure recovery after exercise are associated with a higher risk of hypertension, preclinical and clinical cardiovascular disease and death among middle-aged to older adults. Blood pressure responses to exercise are significant markers […]

July 12, 2018

Researchers at Brigham and Women’s Hospital have engineered cancer cells that track and kill cancer cells. The modified cancer cells have demonstrated anti-cancer efficacy in preclinical studies, destroying both primary and metastatic tumours. Each year over 8 million people die […]

November 21, 2017

A new study, published in the Journal of Clinical Investigation, identified a substance Gdf-15, which is secreted by pancreatic cancer cells and shields cancerous cells from attack by immune cells known as macrophages. The study identified that Gdf-15 may be […]

October 17, 2017

Around 2.5 million people are affected by the autoimmune disease Multiple Sclerosis (MS), the commonest central nervous system disease among young adults. There are around 12,500 MS sufferers in Austria and 400 new cases every year. There is currently no […]

October 6, 2017

Tal Danino, a professor at the Data Science Institute, is conducting research that could help scientists combat the most lethal of cancers: pancreatic cancer. In a recent study, working with a team of researchers, Danino demonstrated that bacteria in pancreatic […]